| Andrew W Parker, MD | |
|
4700 E.hale Pkwy, Ste 550, Denver, CO 80220-4053 | |
| (303) 321-6600 | |
| Not Available |
| Full Name | Andrew W Parker |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 38 Years |
| Location | 4700 E.hale Pkwy, Denver, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215045133 | NPI | - | NPPES |
| 01317965 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0005X | Orthopaedic Surgery - Sports Medicine | 31796 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rose Medical Center | Denver, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopedic Centers Of Colorado | 2365714540 | 298 |
News Archive
The results of a survey conducted by the American Academy of Cosmetic Dentistry showed that virtually all Americans - 99.7 percent to be exact - believe that a nice looking smile is an important physical asset. Dr. Michael Lenz, DMD of Wilmington Dental Associates sees countless patients who don't like the way their teeth look and are eager to improve their smiles at his Wilmington cosmetic dentistry.
Allopurinol, a relatively inexpensive anti-gout medication that has been on the market for more than 20 years, may have some activity against colorectal adenomas, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.
Danaher Corporation today announced record results for the second quarter 2015. For the quarter ended July 3, 2015, non-GAAP adjusted diluted net earnings per share were $1.08, which reflects the adjustments identified in the attached reconciliation schedule. On a GAAP basis, diluted net earnings for the second quarter were $696 million, or $0.97 per share. Revenue for the second quarter 2015 increased 3.5% to $5.1 billion with core revenues also increasing 3.5%.
Researchers led by the University of Birmingham have found a potential new target to treat inflammatory disease.
Here's the dilemma: The only way for the health-care industry to move toward accountable care is to further accelerate a process of consolidation that has already reduced competition and increased market power. … In such a market, government may be required to step in with more direct regulation and competition management than traditional antitrust rules now provide (Steven Pearlstein, 11/23).
› Verified 9 days ago
| Entity Name | Orthopedic Centers Of Colorado |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801339502 PECOS PAC ID: 2365714540 Enrollment ID: O20170823001317 |
News Archive
The results of a survey conducted by the American Academy of Cosmetic Dentistry showed that virtually all Americans - 99.7 percent to be exact - believe that a nice looking smile is an important physical asset. Dr. Michael Lenz, DMD of Wilmington Dental Associates sees countless patients who don't like the way their teeth look and are eager to improve their smiles at his Wilmington cosmetic dentistry.
Allopurinol, a relatively inexpensive anti-gout medication that has been on the market for more than 20 years, may have some activity against colorectal adenomas, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.
Danaher Corporation today announced record results for the second quarter 2015. For the quarter ended July 3, 2015, non-GAAP adjusted diluted net earnings per share were $1.08, which reflects the adjustments identified in the attached reconciliation schedule. On a GAAP basis, diluted net earnings for the second quarter were $696 million, or $0.97 per share. Revenue for the second quarter 2015 increased 3.5% to $5.1 billion with core revenues also increasing 3.5%.
Researchers led by the University of Birmingham have found a potential new target to treat inflammatory disease.
Here's the dilemma: The only way for the health-care industry to move toward accountable care is to further accelerate a process of consolidation that has already reduced competition and increased market power. … In such a market, government may be required to step in with more direct regulation and competition management than traditional antitrust rules now provide (Steven Pearlstein, 11/23).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew W Parker, MD 4700 E.hale Pkwy, Ste 550, Denver, CO 80220-4053 Ph: (303) 321-6600 | Andrew W Parker, MD 4700 E.hale Pkwy, Ste 550, Denver, CO 80220-4053 Ph: (303) 321-6600 |
News Archive
The results of a survey conducted by the American Academy of Cosmetic Dentistry showed that virtually all Americans - 99.7 percent to be exact - believe that a nice looking smile is an important physical asset. Dr. Michael Lenz, DMD of Wilmington Dental Associates sees countless patients who don't like the way their teeth look and are eager to improve their smiles at his Wilmington cosmetic dentistry.
Allopurinol, a relatively inexpensive anti-gout medication that has been on the market for more than 20 years, may have some activity against colorectal adenomas, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.
Danaher Corporation today announced record results for the second quarter 2015. For the quarter ended July 3, 2015, non-GAAP adjusted diluted net earnings per share were $1.08, which reflects the adjustments identified in the attached reconciliation schedule. On a GAAP basis, diluted net earnings for the second quarter were $696 million, or $0.97 per share. Revenue for the second quarter 2015 increased 3.5% to $5.1 billion with core revenues also increasing 3.5%.
Researchers led by the University of Birmingham have found a potential new target to treat inflammatory disease.
Here's the dilemma: The only way for the health-care industry to move toward accountable care is to further accelerate a process of consolidation that has already reduced competition and increased market power. … In such a market, government may be required to step in with more direct regulation and competition management than traditional antitrust rules now provide (Steven Pearlstein, 11/23).
› Verified 9 days ago
Dr. Andrew Volodymyr Pytiak, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2055 N High St Ste 130, Denver, CO 80205 Phone: 303-861-2663 Fax: 303-861-4741 | |
Dr. Edward C Pino Ii, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2045 Franklin St, Denver, CO 80205 Phone: 303-338-4545 | |
John D Douthit Sr., M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 850 E Harvard Ave, Suite 125, Denver, CO 80210 Phone: 303-722-0221 Fax: 303-722-0148 | |
Dr. Richard Won Kang, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2045 N Franklin St, Denver, CO 80205 Phone: 303-338-4545 | |
Dr. Gary W. Hess, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 8101 East Lowry Boulevard, Suite 260, Denver, CO 80230 Phone: 303-214-4500 Fax: 303-214-4571 | |
Richard Fisher, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 4701 E Ninth Ave, Denver, CO 80262 Phone: 303-493-7000 | |
Dr. Jeffrey R Jockel, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2045 N Franklin St, Denver, CO 80205 Phone: 303-338-4545 |